Bumper Offer - Urjas oil Just @ Rs. 1
PPG 0.3 Tablet (30) is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Diabetes Type 2.
The correct dosage of PPG 0.3 Tablet (30) depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
The most common side effects of PPG 0.3 Tablet (30) are Rash, Flatulence, Diarrhoea. Apart from the aforementioned side effects, PPG 0.3 Tablet (30) can also lead to other problems, which have been listed below. Usually, these side effects of PPG 0.3 Tablet (30) go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of PPG 0.3 Tablet (30) is Severe for pregnant women and Severe for women who are breastfeeding. Warnings related to PPG 0.3 Tablet (30)'s effects on the liver, heart and kidney, if any, have been listed below.
PPG 0.3 Tablet (30) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Digestive Disorders, Intestinal Obstruction, Allergy are examples of such conditions. Other conditions have been mentioned below in the PPG 0.3 Tablet (30) contraindications section.
Besides this, PPG 0.3 Tablet (30) may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking PPG 0.3 Tablet (30) is considered safe while driving, and is addictive.
PPG 0.3 Tablet (30) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when PPG 0.3 Tablet (30) is used -
Severe
Mild
Common
Is the use of PPG 0.3 Tablet (30) safe for pregnant women?
PPG has many dangerous side effects in pregnant women. If you are pregnant, do not consume PPG without medical advice.
Is the use of PPG 0.3 Tablet (30) safe during breastfeeding?
PPG should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of PPG 0.3 Tablet (30) on the Kidneys?
PPG rarely affects the kidneys.
What is the effect of PPG 0.3 Tablet (30) on the Liver?
Use of PPG may be dangerous for the liver. Do not use it without doctor's advice.
What is the effect of PPG 0.3 Tablet (30) on the Heart?
PPG is rarely harmful for the heart.
PPG 0.3 Tablet (30) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take PPG 0.3 Tablet (30) unless your doctor advises you to do so -
Is this PPG 0.3 Tablet (30) habit forming or addictive?
Forming a habit of PPG 0.3 Tablet (30) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking PPG 0.3 Tablet (30) as it does not make you drowsy.
Is it safe?
Yes, but consume PPG 0.3 Tablet (30) only on doctor's advice.
Is it able to treat mental disorders?
No, PPG 0.3 Tablet (30) is not used to treat mental disorders.
Interaction between Food and PPG 0.3 Tablet (30)
Due to the absence of research, it is difficult to say how PPG 0.3 Tablet (30) and food will interact.
Interaction between Alcohol and PPG 0.3 Tablet (30)
It is difficult to say anything about the effect of PPG 0.3 Tablet (30) and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
